Introduction
The role of the supplementary motor area (SMA) in the initiation of movement and speech is well documerited. Single unit studies with subhuman primates (1, 2) , evoked responses (3), regional cerebral blood flow studies (4) (5) (6) , and functional magnetic resonance imaging with humans (7) (8) (9) (10) . The (15) and executive dysfunction (16) , following frontal lobe lesions.
The use of single-case experimental designs to determine the efficacy of therapeutic interventions with patients undergoing neurorehabilitation has recently gained increasing acceptance (17, 18 (19, 20) , behavioral intervention (21, 22) , and cognition-enhancing drugs (23, 24) . Using an extended ABAB design (25) Table 2 ). Generalization to ADL and mobility was also assessed by two independent raters following completion of the three-step upper limb baseline/treatment series and prior to discharge. The assessment of functional performance on ADL and mobility was completed using a 7-point scale, the Functional Independence Measure (FIM) (26). 
Results
The subject demonstrated considerable benefit from the intervention in ~the performance of one-, two-, and three-step upper limb movements. Figures 1 and 2 (Kazdin, 1982) . Autocorrelations for adjacent data points were nonsignificant for both the onestep and two-step movements series, demonstrating the absence of serial dependency. Figure 3 shows the effect of treatment on three-step arm/hand movements. During the initial baseline assessment of three-step movements (days [10] [11] [12] [13] [14] , mean time to completion was 164 seconds. The introduction of the cuing sequence on days [15] [16] resulted in a decrease in time to completion to a series mean of 72 seconds. Withdrawal of treatment ondays [17] [18] [19] produced an increase in initiation/duration time to a series mean of 148.6 seconds. Continuation of this pattern resulted in a decrease in duration to a series mean of 57 seconds during treatment on days 20-23, followed by an increase to a mean of 129.5 seconds during treatment withdrawal on days [24] [25] 
